Skip to content
About Us
Why IDDI
Therapeutic Expertise
Leadership
News
Events
Research Projects
Services
Biostatistics
Biostatistical Analysis
Interim Analysis – IDMC
ADaM – Data Standards Implementation
PK/PD
Clinical Data Management
SDTM – Data Standards Implementation
Strategic Consulting
Study Design
Regulatory Statistics
eClinical Technologies
One2Treat
Randomization & Trial Supply Management
Electronic Data Capture
Resources
Careers
Contact
Open Search
Search
X
Close Menu
About Us
Why IDDI
Therapeutic Expertise
Leadership
News
Events
Research Projects
Services
Biostatistics
Biostatistical Analysis
Interim Analysis – IDMC
ADaM – Data Standards Implementation
PK/PD
Clinical Data Management
SDTM – Data Standards Implementation
Strategic Consulting
Study Design
Regulatory Statistics
eClinical Technologies
One2Treat
Randomization & Trial Supply Management
Electronic Data Capture
Resources
Careers
Contact
Close Menu
Phase III Trials
Blog
Why Phase 3 Clinical Trials Fail And What Your First Childhood Crush Can Teach You About It
June 10, 2025
Webinar
Good Morning Meeting | Optimizing the Transition From Early to Late Phase Trials in Oncology
September 19, 2023
Webinar
Why Do So Many Phase III Clinical Trials Fail?
December 6, 2022
Webinar
Conversation Between a Sponsor and a Statistician About Phase II/III Trials in Oncology
June 23, 2022
Article
Considerations on the Mechanics and Sample Sizes for Early Trials of Targeted Agents and Immunotherapy in Oncology
June 28, 2021
When every data point represents a patient, accuracy and integrity aren’t optional — they’re everything.
That’s why it’s IDDI.
Start Now